Search Results 161-170 of 13180 for pharmacogenetics
Learn how genetic testing can help customize your cancer treatment plan. Precision medicine is improving breast cancer diagnosis, treatment and prevention.
Mayo Clinic physicians are committed to collaborating with referring physicians. Telephone consultations and referrals may be arranged by contacting the ...
Mayo Clinic's Immuno-Epigenetics Lab focuses on T-cell epigenetic programming, immunometabolism and inflammatory signaling, multi-omic and systems ...
The research interests of Ann M. Moyer, M.D., Ph.D., are in the development of genetic tests for primary immunodeficiencies and pharmacogenomics, as well as the ...
Helix to generate clinical whole genome sequencing and multi-omics data from one million biospecimens, advancing precision medicine as the standard of care ...
The purpose of this study is to evaluate the integration of cancer pan-genetic testing into a cancer clinical practice and understand both its use and effect in ...
View funding sources for the Epigenetic Etiology of Human Disease Lab led by Keith Robertson, Ph.D., at Mayo Clinic's campus in Minnesota.
Overview Tab Title Description Study type Observational Study IDs Study type Observational Describes the nature of a clinical study.
Cholangiocarcinoma (CCA) is an aggressive cancer that forms in the cells that line the bile duct. The only treatment options include aggressive chemotherapy ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Last chance! Your gift today has 5X the power to fuel medical progress using AI.